UroGen appoints Dr. Leana Wen to board and audit committee

UroGen Pharma Ltd.

Dr. Wen appointed to fill vacancy; term runs until 2023 annual meeting.
Received initial option for 20,000 ordinary shares vesting quarterly over 12 quarters.
Annual retainer of $40,000 for board service plus $7,500 for audit committee.
Eligible for annual option grant of 10,000 ordinary shares at each shareholder meeting.
Company entered standard director indemnity agreement with Dr. Wen.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Leana Wen

Director

URGN · UroGen Pharma Ltd.

Effective: 2022-09-08
Filed: September 12, 2022, 7:59 PM ET

On September 8, 2022, Leana Wen, M.D., MSc was appointed to the board of directors (the “Board”) of UroGen Pharma Ltd., an Israeli company (the “Company”), to fill a vacancy on the Board and to hold office until the Company’s 2023 Annual Meeting of Shareholders and was also appointed to the Audit Committee of the Board.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Leana Wen was appointed as Director at UroGen Pharma Ltd..

Action: appointed
Role: Director

Exact text from the filing

On September 8, 2022, Leana Wen, M.D., MSc was appointed to the board of directors (the “Board”) of UroGen Pharma Ltd., an Israeli company (the “Company”), to fill a vacancy on the Board and to hold office until the Company’s 2023 Annual Meeting of Shareholders and was also appointed to the Audit Committee of the Board.

View on SEC.gov

UroGen Pharma Ltd. filing history →

Source: SEC EDGAR

accession 0001437749-22-022160

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.